Group Structure Comprising Consolidated Subsidiaries and Equity-Method Affiliates
First written in FY2016. . Latest entry: FY2026.
18 other companies' latest entry also says "Other".
- FY2026Restructuring of the consolidation scope through new acquisitions, incorporations, disposals and mergers between subsidiariesAnnual report
「As of 31 March 2026, the Group consisted of the Company, 51 consolidated subsidiaries and 5 associates accounted for under the equity method,」
The scope of consolidation was expanded and reorganized through consolidation following new acquisitions and the establishment of new companies, the removal of 2 companies from the scope of consolidation, multiple mergers between subsidiaries, and the addition of equity-method affiliates. - FY2026-H1Expansion and reorganization of the scope of consolidation through new acquisitions, newly established companies and mergers between subsidiariesAnnual report
「During the current interim consolidated accounting period, ㈱テックインターナショナル and デルフィア㈱ were included in the scope of consolidation following the acquisition of their shares, while マスターズフォレスト㈱ was included following its establishment.」
In addition to 2 newly acquired companies and 1 newly established company being added to the scope of consolidation, mergers between subsidiaries were carried out in the キングラン, dispensing pharmacy and food service businesses, expanding and reorganizing the group structure. マネジメントビットバレー㈱ and PT SAMATOR CNU TEHNOLOGI MEDIKA were also added to the scope of equity-method accounting. - FY2025Changes to the scope of consolidation through the reorganization, sale and new acquisition of consolidated subsidiariesAnnual report
「As of 31 March 2025, the Group consisted of the Company, 57 consolidated subsidiaries and 3 associates accounted for under the equity method,」
The number of consolidated subsidiaries became 57. ＭＯＮＡＫＡ was newly acquired, アゴラジャパン was removed from the scope of consolidation following the transfer of all its shares, and multiple mergers by absorption between consolidated subsidiaries were carried out, reorganizing the group structure. - FY2025-H1Changes to the scope of consolidation through mergers between subsidiaries and new acquisitionsAnnual report
「During the current interim consolidated accounting period, シップヘルスケアファーマシー東日本㈱, a consolidated subsidiary, absorbed ㈲Ｃ.Ｍ.Ｊ and ㈲フレンズ, which had also been consolidated subsidiaries. In addition, ㈱ＭＯＮＡＫＡ was included in the scope of consolidation following the acquisition of its shares.」
Ｃ.Ｍ.Ｊ and フレンズ were merged by absorption, while ＭＯＮＡＫＡ was acquired and consolidated, resulting in changes to the group structure and scope of consolidation. - FY2024-Q3Merger between subsidiaries and addition to the scope of consolidationAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary ㈱サンライフ merged with ティック㈱, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈱エヌジェイメディカル was included in the scope of consolidation following the newly acquired shares.」
The group structure and scope of consolidation changed following the merger by absorption of ティック㈱ by サンライフ and the acquisition and consolidation of ㈱エヌジェイメディカル. - FY2024-Q2Merger between consolidated subsidiaries, new acquisitions and changes to the scope of equity-method accountingAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with ㈲菜の花薬局, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈲Ｃ.Ｍ.Ｊ and ㈲フレンズ were included in the scope of consolidation following the newly acquired shares.」
In addition to the merger by absorption of 菜の花薬局 and the consolidation of Ｃ.Ｍ.Ｊ and フレンズ, the group structure was changed following the completion of the liquidation of an equity-method affiliate and its removal from the scope of equity-method accounting. - FY2024-Q1Removal from consolidation following the transfer of all shares in a consolidated subsidiaryAnnual report
「During the first quarter of the consolidated fiscal year, all shares in ㈱セントラルユニコリア, which had been a consolidated subsidiary of the Company, were transferred, and the company was removed from the scope of consolidation.」
The group structure was changed in a manner that reduced the scope of consolidation through the transfer of all shares in ㈱セントラルユニコリア. - FY2023-Q3Addition to the scope of consolidationAnnual report
「During the third quarter of the consolidated fiscal year, ㈱オールケアー was included in the scope of consolidation following the newly acquired shares.」
The scope of consolidation was further expanded through the acquisition of shares in ㈱オールケアー. - FY2023-Q2Further expansion of the scope of consolidation and merger between subsidiariesAnnual report
「In addition, キングラン㈱ and its subsidiaries キングラン・メディケア㈱, キングランリニューアル㈱ and グラン・グルメ㈱, as well as 8 other companies and ㈲菜の花薬局, were included in the scope of consolidation following the acquisition of their shares.」
キングラン㈱ and its 11 subsidiaries, as well as 菜の花薬局, were newly added to the scope of consolidation. In addition, 4 mergers by absorption between consolidated subsidiaries were carried out, expanding and reorganizing the group structure. - FY2023-Q1Addition to the scope of consolidationAnnual report
「During the first quarter of the current consolidated fiscal year, ㈱中央 was included in the scope of consolidation following the acquisition of its shares.」
The scope of consolidation was expanded through the acquisition of shares in ㈱中央. The consolidation of キングラン株式会社 is disclosed as a subsequent event dated 1 July 2022. - FY2022Further expansion of the scope of consolidation and merger between subsidiariesAnnual report
「㈲ケイツーファーマシー, ㈲寿老会, ㈱ハッピーケア, ㈱トム・メディック and its subsidiary ㈱ＨＤ－メディカルコミニュケーションズ, and ㈱hana were included in the scope of consolidation from the current consolidated fiscal year because their shares were newly acquired.」
The scope of consolidation expanded to include 6 newly acquired companies, including マスターズホスピタリティ, which moved from equity-method accounting to consolidation. Mergers by absorption between consolidated subsidiaries also continued. - FY2022-Q3Merger between subsidiaries and addition to the scope of equity-method accountingAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with カインドネス㈲ and ㈲ケイツーファーマシー, which had also been consolidated subsidiaries, through an absorption-type merger.」
An additional merger by absorption between consolidated subsidiaries was carried out in the third quarter. In the first quarter, 住商至誠医養健康服務(山東)有限公司 was added to the scope of equity-method accounting, and the reorganization and expansion of the group structure continued. - FY2022-Q2Merger between subsidiaries and addition to the scope of consolidationAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary グリーンファーマシー㈱ merged with ㈱オオサカ薬局, which had also been a consolidated subsidiary, through an absorption-type merger.」
An additional merger by absorption between subsidiaries was carried out. In the first quarter, 3 newly acquired companies and 1 former equity-method affiliate were added to the scope of consolidation, and a new company was also added to the scope of equity-method accounting. - FY2022-Q1Further expansion of the scope of consolidation and merger between subsidiariesAnnual report
「During the first quarter of the current consolidated fiscal year, ㈱エフエスユニマネジメント absorbed ㈱チェーンマネジメント, ㈱SMC absorbed メディカルツーリズム・ジャパン㈱, and シップヘルスケアファーマシー東日本㈱ absorbed ㈱M'sファーマシー. These were all organizational restructurings between consolidated subsidiaries. In addition, ㈲ケイツーファーマシー, ㈲寿老会 and ㈱ハッピーケア were included in the scope of consolidation following the acquisition of their shares, and マスターズホスピタリティ㈱, which had been an equity-method affiliate through the previous consolidated fiscal year, was included in the scope of consolidation based on the substantive control criterion.」
In addition to 3 mergers by absorption between consolidated subsidiaries, 3 newly acquired companies and 1 former equity-method affiliate were added to the scope of consolidation, resulting in a change to the group structure. - FY2021Further expansion of the scope of consolidation and merger between subsidiariesAnnual report
「The group consists of the Company, 55 consolidated subsidiaries, and 4 associates accounted for under the equity method, as of 31 March 2021,」
In addition to the acquisition and consolidation of companies in Myanmar, オオサカ薬局 and ㈲カインドネス, multiple mergers between consolidated subsidiaries were carried out, increasing the number of consolidated subsidiaries from 53 to 55. - FY2021-Q3Addition to the scope of consolidation and merger between subsidiariesAnnual report
「During the third quarter of the current consolidated fiscal year, 小西医療器㈱ absorbed 小西共和ホールディング㈱ and 共和医理器㈱, while シップヘルスケアファーマシー東日本㈱ absorbed ㈲ウィル・ウエイ and ㈱ふれあい. These were all organizational restructurings between consolidated subsidiaries. In addition, ㈲カインドネス was included in the scope of consolidation following the acquisition of its shares.」
The group structure was reorganized through mergers by absorption between consolidated subsidiaries, while the scope of consolidation was also expanded through the acquisition and consolidation of ㈲カインドネス. - FY2021-Q2Addition to the scope of consolidationAnnual report
「During the second quarter consolidated accounting period, 株式会社オオサカ薬局 was included in the scope of consolidation following the acquisition of additional shares.」
The group structure was further expanded through the acquisition and consolidation of オオサカ薬局. - FY2021-Q1Addition to the scope of consolidation and merger between subsidiariesAnnual report
「During the first quarter of the current consolidated fiscal year, ㈱日本ネットワークサービス, a consolidated subsidiary, absorbed ㈱アネット, which had also been a consolidated subsidiary. In addition, Okkar Thiri Co., Ltd. and its subsidiary Okkar Thiri Trading Pte. Ltd., Snow Everest Co., Ltd. and its subsidiary Snow Everest Trading Pte. Ltd., and ㈱エス・ティー・ケー were included in the scope of consolidation following the acquisition of their shares.」
In addition to the merger by absorption of アネット, 2 companies in Myanmar and their subsidiaries, as well as ㈱エス・ティー・ケー, were added to the scope of consolidation. The scope of equity-method accounting also expanded following the acquisition of an interest in CHARM CARE CORPORATION. - FY2020Further expansion of the consolidation scopeAnnual report
「As of 31 March 2020, the Group consisted of the Company, 53 consolidated subsidiaries and 2 associates accounted for under the equity method,」
I&C, 日本システム家具, ジョイアップ, 日本ネットワークサービス, アネット, ふれあい and Ｍ'ｓファーマシー were newly consolidated, bringing the number of consolidated subsidiaries to 53. - FY2020-Q3Addition to the scope of consolidationAnnual report
「During the third quarter of the consolidated fiscal year, ㈱日本ネットワークサービス, its subsidiary ㈱アネット, and ㈱ふれあい were included in the scope of consolidation following the newly acquired shares.」
日本ネットワークサービス, together with its subsidiaries アネット and ふれあい, was consolidated following the acquisition of their shares, further expanding the group structure. - FY2020-Q2Addition to the scope of consolidationAnnual report
「During the second quarter of the consolidated fiscal year, ㈱日本システム家具 and ㈱ジョイアップ were included in the scope of consolidation following the newly acquired shares.」
日本システム家具 and ジョイアップ were consolidated following the acquisition of their shares, further expanding the group structure. - FY2020-Q1Merger by absorption between subsidiaries and addition to the scope of consolidationAnnual report
「During the first quarter of the current consolidated fiscal year, シップヘルスケアファーマシー東日本㈱, a consolidated subsidiary, absorbed ㈲花梨薬局, which had also been a consolidated subsidiary. In addition, ㈱I&C was included in the scope of consolidation following the acquisition of its shares.」
In addition to a merger by absorption between consolidated subsidiaries, ㈱I&C was consolidated following the acquisition of its shares, resulting in a change to the group structure. - FY2019-Q3Merger by absorption between subsidiaries and addition to the scope of consolidationAnnual report
「During the third quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with ㈲なごみ薬局, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, ㈲ウィル・ウエイ was included in the scope of consolidation following the newly acquired shares.」
Organizational restructuring progressed through a merger by absorption between existing consolidated subsidiaries, while the scope of consolidation was also expanded through the acquisition of shares in ウィル・ウエイ. - FY2019-Q2Structural change through a merger by absorption between subsidiariesAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary ㈱エフエスユニ merged with ㈱ＡＭＣ, which had also been a consolidated subsidiary, through an absorption-type merger. In addition, the consolidated subsidiary ㈱エフエスユニマネジメント merged with ㈱ヘルスケアリソースマネジメント, which had also been a consolidated subsidiary, through an absorption-type merger.」
2 mergers by absorption were carried out between existing consolidated subsidiaries, resulting in the reorganization of the group structure rather than an addition to the scope of consolidation. - FY2019-Q1Structural change through a merger by absorption between subsidiariesAnnual report
「During the first quarter of the consolidated fiscal year, the consolidated subsidiary シップヘルスケアファーマシー東日本㈱ merged with みどり調剤㈲, which had also been a consolidated subsidiary, through an absorption-type merger.」
The group structure changed through a merger by absorption between existing consolidated subsidiaries, rather than through additions to the scope of consolidation. - FY2018Addition to the scope of consolidation and organizational restructuringAnnual report
「As of 31 March 2018, the Group consisted of the Company, 50 consolidated subsidiaries and 3 associates accounted for under the equity method,」
The number of consolidated subsidiaries became 50 following the consolidation of ユーロメディテック, 花梨薬局, オルガンメディカル and なごみ薬局, as well as a merger by absorption between subsidiaries. - FY2018-Q3Merger by absorption between subsidiaries and addition to the scope of consolidationAnnual report
「During the third quarter of the current consolidated fiscal year, 小西医療器㈱, a consolidated subsidiary, absorbed ㈱野上器械店, which had also been a consolidated subsidiary. 日本パナユーズ㈱, also a consolidated subsidiary, absorbed 大阪パナユーズ㈱, which had likewise been a consolidated subsidiary. In addition, ㈲オルガンメディカル was included in the scope of consolidation following the acquisition of its shares.」
In addition to 2 mergers by absorption between subsidiaries, ㈲オルガンメディカル was consolidated following the acquisition of its shares, resulting in a change to the group structure. - FY2018-Q2Structural change through a merger by absorption between subsidiariesAnnual report
「During the second quarter of the consolidated fiscal year, the consolidated subsidiary オーラムメディカル㈱ merged with ㈱TMA, which had also been a consolidated subsidiary, through an absorption-type merger.」
Although there were no additions to the scope of consolidation itself, a merger by absorption was carried out between existing consolidated subsidiaries, and the group structure was reorganized. - FY2018-Q1Further expansion of the consolidation scopeAnnual report
「During the first quarter of the consolidated fiscal year, ユーロメディテック㈱ and ㈲花梨薬局 were included in the scope of consolidation following the newly acquired shares.」
2 new companies were consolidated through share acquisitions, further expanding the group structure. - FY2017-Q3Further expansion of the consolidation scopeAnnual report
「During the third quarter of the current consolidated fiscal period, 昭島国際法務PFI㈱ was included in the consolidation scope following its incorporation. Ship Aichi Medical Service, Ltd. was also included in the consolidation scope as its materiality increased.」
The newly incorporated 昭島国際法務PFI㈱ and Ship Aichi Medical Service, Ltd., whose materiality increased, became consolidated entities, further expanding the group structure. - FY2017-Q2Further expansion of the consolidation scopeAnnual report
「During the second quarter of the current consolidated fiscal period, 日本パナユーズ㈱ and its subsidiary 大阪パナユーズ㈱ were included in the consolidation scope following the acquisition of their shares.」
Following 小西共和ホールディング and its 4 subsidiaries, 日本パナユーズ and 大阪パナユーズ were also added to the consolidation scope, further expanding the group structure. - FY2017-Q1Expansion of Consolidation ScopeAnnual report
「During the first quarter of the current consolidated fiscal period, 小西共和ホールディング㈱ and its 4 subsidiaries became consolidated subsidiaries following the acquisition of their shares.」
The consolidation of 小西共和ホールディング and its 4 subsidiaries expanded the group-company structure. - FY2016First statedAnnual report
「As of 31 March 2016, the group consisted of the Company, 42 consolidated subsidiaries and 4 affiliated companies accounted for under the equity method,」
The group structure, with numerous subsidiaries and affiliated companies, forms the foundation for economies of scale, synergies and the management structure.